Pisa Syndrome secondary to rivastigmine: A case report

Clinica Terapeutica

Volumn 163, Issue 1, 2012, Pages 31-32

  Leelavathi, M ^a   Rosdinom, R ^a   Suguna, M ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b Selangor Medical Center   (Malaysia)

Author keywords

Cholinergic drug; Pisa syndrome; Pleurothotonus; Rivastigmine

Indexed keywords

DONEPEZIL; OLANZAPINE; RIVASTIGMINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELUSION; DEMENTIA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; INVOLUNTARY MOVEMENT; MALE; MOTOR DYSFUNCTION; PISA SYNDROME; RANGE OF MOTION; TREATMENT RESPONSE;

AGED; BENZODIAZEPINES; CHOLINESTERASE INHIBITORS; DELUSIONS; DEMENTIA; HUMANS; INDANS; MALE; MOVEMENT DISORDERS; PHENYLCARBAMATES; PIPERIDINES; POSTURE; SYNDROME;

EID: 84858376212     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Susuki T, Matsuzaka H. D. Drug-induced Pisa syndrome: epidemiology and mamagement. CNS Drugs 2002; 3:165-72
2. Yokochi F. Lateral fl exion in Parkinson's disease and Pisa syndrome. J Neurol 2006; 253(7)17-20
3. Cordeiro Q, Zung S, Vallada H. Pisa syndrome induced by rapid increase and high dosage of risperidone. Arq Neuropsiquiatr 2008; 66(4):896-97
4. Stubner S, Padberg F, Grohmann R, et al. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 2000; 61(8):569-74
5. Villarejo A, Camacho A, Garcia-Ramos R, et al. Cholinergicdopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 2003; 26(3):119-21
6. Cannas A, Solla P, Floris G, et al. Reversible Pisa syndrome in Parkinson's disease during treatment with Pergolide: a case report. Clin Neuropharmacol 2005; 28(5):252
7. Vanacore N, Suzzareddu G, Maggini M, et al. Pisa syndrome in a cohort of Alzheimer's disease patient. Acta Neurol Scand 2005; 111:199-201
8. Wang HQ, Chiu JH. Rivastigmine induced Pisa Syndrome. Taiwanese Journal of Psychiatry 2008: 22(2):154-58
9. Cossu G, Melis M, Melis G, et al. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. Mov Disord 2004; 19(10):1243-4
10. Kwak YT, Han IW, Baik J, et al. Relation between cholinesterase inhibitor and Pisa syndrome. Lancet 2000; 355(9222):2222